| 引用本文: |
曹如柔,周坚,王其美,章茜,王容容,陈茂.莪术二酮通过VEGF/VEGFR2信号通路对肝癌HepG2细胞微环境下HHSEC增殖的影响[J].湖南中医药大学学报,2021,41(12):1835-1839[点击复制] |
|
| |
|
|
| 本文已被：浏览 1956次 下载 1111次 |
| 莪术二酮通过VEGF/VEGFR2信号通路对肝癌HepG2细胞微环境下HHSEC增殖的影响 |
| 曹如柔,周坚,王其美,章茜,王容容,陈茂 |
| (湖南中医药大学, 湖南 长沙 410208;湖南省中医药研究院附属医院肿瘤科, 湖南 长沙 410006) |
| 摘要: |
| 目的 探讨莪术二酮对肝癌HepG2细胞微环境下的人肝窦内皮细胞（human hepatic sinusoidal endothelial cells，HHSEC）增殖的抑制作用，并阐明其可能机制。方法 CCK-8法检测不同浓度（0.5%、1%、2%、4%、8%）的HepG2细胞上清液处理HHSEC后的细胞增殖率；HHSEC分为空白组、阳性对照组及莪术二酮低、中、高剂量组，分别予以M199培养基、含1 μg/L顺铂注射液的M199培养基、0.5、1、2 μg/L浓度的莪术二酮工作液培养。应用RT-PCR法和Western blot法检测不同浓度莪术二酮干预后HHSEC内的VEGF、VEGFR2 mRNA及蛋白表达情况。结果 2%、4%及8%的HepG2细胞上清液可促进HHSEC的增殖（P<0.05）；在4% HepG2细胞上清液作用下，0.5、1、2 μg/L莪术二酮均可抑制HepG2细胞上清液对HHSEC的增殖作用（P<0.05），随着浓度的增加，HHSEC增殖率降低明显，不同浓度组间差异均有统计学意义（P<0.05）。在HepG2细胞微环境下，与空白组相比，莪术二酮高剂量组HHSEC中VEGF mRNA和蛋白表达明显降低（P<0.01），莪术二酮中、高剂量组VEGFR2 mRNA和蛋白的表达均明显降低（P<0.01）。结论 莪术二酮对HepG2细胞微环境下的HHSEC具有抗增殖活性，其作用机制可能与抑制HepG2细胞微环境下HHSEC中VEGF和VEGFR2的表达有关。 |
| 关键词: 肝癌 莪术二酮 VEGF/VEGFR2 HepG2细胞 人肝窦内皮细胞 |
| DOI：10.3969/j.issn.1674-070X.2021.12.004 |
| 投稿时间：2020-10-24 |
| 基金项目:湖南省中医药研究院科研课题（201711）。 |
|
| The Effect of the Curdione on the Proliferation of HHSEC Under the Microenvironment of HepG2 Cells via VEGF/VEGFR2 Signaling Pathway |
| CAO Rurou,ZHOU Jian,WANG Qimei,ZHANG Xi,WANG Rongrong,CHEN Mao |
| (Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;Department of Oncology, The Affiliated Hospital of Hunan Academy of Chinese Medicine, Changsha, Hunan 410006, China) |
| Abstract: |
| Objective To explore the inhibitory effect of curdione on the proliferation of human hepatic sinusoidal endothelial cells (HHSEC) in the microenvironment of liver cancer HepG2 cells, and to clarify its possible mechanism. Methods CCK-8 method was used to detect the cell proliferation rate of HepG2 cells supernatants of different concentrations (0.5%, 1%, 2%, 4%, 8%) after HHSEC treatment; HHSEC was divided into blank group, positive control group and curdione low, medium, and high-dose groups, and were cultured with M199 medium, M199 medium containing 1 μg/L cisplatin injection, and working solution of curdione at 0.5, 1, and 2 μg/L. RT-PCR and Western blot were used to detect the expression of VEGF and VEGFR2 mRNA and protein in HHSEC after the intervention of different concentrations of curdione. Results 2%, 4% and 8% of HepG2 cells supernatants can promote the proliferation of HHSEC (P<0.05); under the action of 4% HepG2 cells supernatants, 0.5, 1, 2 μg/L curdione can inhibit the proliferation effect of HepG2 cells supernatant on HHSEC (P<0.05). With the increase of concentration, the proliferation rate of HHSEC decreased significantly, and the differences between groups of different concentrations were statistically significant (P<0.05). In the microenvironment of HepG2 cells, compared with the blank group, the expression of VEGF mRNA and protein in HHSEC of the curdione high-dose group was significantly reduced (P<0.01), and the expression of VEGFR2 mRNA and protein in curdione middle and high-dose group were both decreased (P<0.01). Conclusion Curdione has anti-proliferative activity on HHSEC in HepG2 cells microenvironment, and its mechanism of action may be related to inhibiting the expression of VEGF and VEGFR2 in HHSEC in HepG2 cells microenvironment. |
| Key words: hepatic carcinoma curdione VEGF/VEGFR2 HepG2 cells human hepatic sinusoidal endothelial cells |
|
二维码（扫一下试试看！） |
|
|
|
|
